# Evaluating Gut Imaging and Stool Biomarkers in Patients With Scleroderma-associated Gastrointestinal Disease

> **NCT04630782** · — · UNKNOWN · sponsor: **Singapore General Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Systemic Sclerosis
- Scleroderma

## Interventions

- **DIAGNOSTIC_TEST:** PET-MRI scan

## Key facts

- **NCT ID:** NCT04630782
- **Lead sponsor:** Singapore General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-09
- **Primary completion:** 2023-01-31
- **Final completion:** 2023-01-31
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2020-11-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04630782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04630782, "Evaluating Gut Imaging and Stool Biomarkers in Patients With Scleroderma-associated Gastrointestinal Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04630782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*